Results 101 to 110 of about 8,056 (296)

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang   +12 more
wiley   +1 more source

Targeting Peace: Understanding UN and EU Targeted Sanctions

open access: yes, 2011
In recent years, the international community has increasingly come to abandon the use of comprehensive sanctions in favour of targeted sanctions. Unlike adopting a coercive strategy on entire states, actors like the United Nations (UN) and the European ...
ERIKSSON, Mikael
core  

Reducing the inequality: Cross-sectional effects of financial sanctions on households and firms in Russia

open access: yes, 2022
Financial sanctions can have varying effects on different parts of the economy and population in a targeted country. This column analyses the effects of the sanctions imposed on Russia following the 2014 annexation of Crimea.
Ongena, Steven; https://orcid.org/   +2 more
core  

Due Process in UN Targeted Sanctions

open access: yes, 2020
Sanctions are an important tool for the UN Security Council to achieve its strategic objectives. Given the increasing number of legal challenges to UN targeted sanctions, particularly in relation to conflict-related and nonproliferation regimes, how can ...
Cockayne, James, Brubaker, Rebecca Adams
core   +1 more source

Deconstructing the Sino-Russian Janus-Faced Approach to Unilateral Sanctions

open access: yesGerman Law Journal
This Article examines the evolving stance of Russia and China on the use of sanctions, highlighting a notable shift from their traditional opposition to unilateral coercive measures toward increasingly employing such tools themselves.
Daniele Musmeci
doaj   +1 more source

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

More harm than good? : Exploring the effects of targeted sanctions on rebel groups' violence against civilians

open access: yes, 2022
Targeted sanctions have become a commonly used conflict management tool over the last decades. Yet, operating in the state-centric context, previous research has highlighted the unintended negative effects of the instrument.
Löfström, Amanda
core  

Home - About - Disclaimer - Privacy